Stock Track | B&K CORP-B Plummets 8.38% in Intraday Trading on Weak Hong Kong Debut
Stock Track
Dec 22
B&K CORP-B (02396) saw its shares plummet by 8.38% during intraday trading on Monday, following a disappointing debut on the Hong Kong Stock Exchange.
The stock opened at HK$33.8 per share, significantly below its offer price of HK$38.2, reflecting investor skepticism or lack of confidence in the company's valuation. This weak debut led to a sharp decline in the stock's price during early trading.
B&K CORP-B is a China-based biopharmaceutical company specializing in protein-based therapies, particularly PDGF drugs for wound healing. The company raised approximately HK$600 million in net proceeds from its IPO, but the early drop in share price suggests challenges in gaining market traction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.